Top

Trials

Published in:

Open Access 01-12-2022 | Dementia | Study protocol

Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial

Authors: Stephanie Book, Michael Jank, Anna Pendergrass, Elmar Graessel

Published in: Trials | Issue 1/2022

Abstract

Background

People with mild cognitive impairment (MCI) are at increased risk of converting to dementia. Cognitive training can improve the cognitive abilities of people with MCI. Computerised cognitive training (CCT) offers several advantages over traditional paper-and-pencil cognitive training and has the potential to be more individualised by matching task difficulty with individual performance. Recent systematic reviews have reported promising effects of CCT on improving the cognitive capacities of people with MCI. However, the quality of existing studies has been limited, and it is still unclear whether CCT can influence the progression to dementia. We developed an ‘individualised’ CCT (MAKSCog) specialised for people with MCI that automatically matches task difficulty with individual performance and an active control training (‘basic’ CCT). The aims of the present study are (a) to evaluate MAKSCog and (b) to investigate whether it can be applied to maintain the cognitive abilities of people with MCI.

Methods

The present study investigates the effects of CCT on cognition in a randomised controlled intervention study in Germany. Participants are community-dwelling people with a psychometric diagnosis of MCI based on the Montreal Cognitive Assessment (MoCA) and Mini-Mental Status Test (MMSE). Screening and baseline testing are conducted via a videoconferencing assessment and telephone. Participants are randomly allocated. The treatment phase is 6 months with an open phase in which participants can freely decide to continue to use the CCTs. Additionally, both CCTs contain a monthly computerised cognitive assessment that measures different cognitive abilities: information processing speed, memory span, short term memory, and logical reasoning.

Discussion

This is the first study to investigate the effect of MAKSCog, an individualised CCT, specifically developed for people with different subtypes of MCI. A methodological strength is the double-blind, randomised, controlled design and the use of basic CCT as an active control group. The study is conducted entirely virtually with valid telehealth assessments for cognitive function. Methodological limitations might include a restriction to participants who feel comfortable with the use of technology and who own a computer, laptop, or tablet.

Trial registration

ISRCTN ISRCTN14437015. Prospectively registered on 27 February 2020.

World Health Organization. Dementia: a public health priority. Geneva: World Health Organization; 2012.

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–8. https://doi.org/10.1001/archneur.56.3.303.CrossRefPubMed

Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94. https://doi.org/10.1111/j.1365-2796.2004.01388.x.CrossRefPubMed

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment. J Intern Med. 2004;256(3):240–6. https://doi.org/10.1111/j.1365-2796.2004.01380.x.CrossRefPubMed

Nygard L. Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment? Acta Neurol Scand Suppl. 2003;179:42–6. https://doi.org/10.1034/j.1600-0404.107.s179.8.x.CrossRefPubMed

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–35.CrossRef

Inui Y, Ito K, Kato T. Longer-term investigation of the value of 18F-FDG-PET and magnetic resonance imaging for predicting the conversion of mild cognitive impairment to Alzheimer's disease: a multicenter study. J Alzheimers Dis. 2017;60(3):877–87. https://doi.org/10.3233/JAD-170395.CrossRefPubMedPubMedCentral

Cheng S-T. Cognitive reserve and the prevention of dementia: The role of physical and cognitive activities. Curr Psychiatry Rep. 2016;18(9):85. https://doi.org/10.1007/s11920-016-0721-2.CrossRefPubMedPubMedCentral

Faucounau V, Wu YH, Boulay M, De Rotrou J, Rigaud AS. Cognitive intervention programmes on patients affected by mild cognitive impairment: a promising intervention tool for MCI? J Nutr Health Aging. 2010;14(1):31–5. https://doi.org/10.1007/s12603-010-0006-0.CrossRefPubMed

10.

Kueider AM, Parisi JM, Gross AL, Rebok GW. Computerized cognitive training with older adults: a systematic review. PLoS One. 2012;7(7):e40588. https://doi.org/10.1371/journal.pone.0040588.CrossRefPubMedPubMedCentral

11.

Zhang H, Huntley J, Bhome R, Holmes B, Cahill J, Gould RL, et al. Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e027062. https://doi.org/10.1136/bmjopen-2018-027062.CrossRefPubMedPubMedCentral

12.

Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A. Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry. 2017;174(4):329–40. https://doi.org/10.1176/appi.ajp.2016.16030360.CrossRefPubMed

13.

Ge S, Zhu Z, Wu B, McConnell ES. Technology-based cognitive training and rehabilitation interventions for individuals with mild cognitive impairment: a systematic review. BMC Geriatr. 2018;18(1):213. https://doi.org/10.1186/s12877-018-0893-1.CrossRefPubMedPubMedCentral

14.

Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: systematic review of the literature. Am J Geriatr Psychiatry. 2015;23(4):335–59. https://doi.org/10.1016/j.jagp.2014.04.009.CrossRefPubMed

15.

Chandler MJ, Parks AC, Marsiske M, Rotblatt LJ, Smith GE. Everyday impact of cognitive interventions in mild cognitive impairment: a systematic review and meta-analysis. Neuropsychol Rev. 2016;26(3):225–51. https://doi.org/10.1007/s11065-016-9330-4.CrossRefPubMedPubMedCentral

16.

Hu M, Wu X, Shu X, Hu H, Chen Q, Peng L, et al. Effects of computerised cognitive training on cognitive impairment: a meta-analysis. J Neurol. 2019;268(5):1680–8. https://doi.org/10.1007/s00415-019-09522-7.CrossRefPubMed

17.

Gates NJ, Vernooij RW, Di Nisio M, Karim S, March E, Martinez G, et al. Computerised cognitive training for preventing dementia in people with mild cognitive impairment. Cochrane Database Syst Rev. 2019;3:CD012279. https://doi.org/10.1002/14651858.CD012279.pub2.CrossRefPubMed

18.

Irazoki E, Contreras-Somoza LM, Toribio-Guzman JM, Jenaro-Rio C, van der Roest H, Franco-Martin MA. Technologies for cognitive training and cognitive rehabilitation for people with mild cognitive impairment and dementia. a systematic review. Front Psychol. 2020;11:648. https://doi.org/10.3389/fpsyg.2020.00648.CrossRefPubMedPubMedCentral

19.

Eichenseer B, Graesel E. Aktivierungstherapie für Menschen mit Demenz: motorisch, alltagspraktisch, kognitiv, spirituell. 2nd ed. München: Elsevier; 2015.

20.

Straubmeier M, Behrndt E-M, Seidl H, Özbe D, Luttenberger K, Graessel E. Non-pharmacological treatment in people with cognitive impairment: results from the randomized controlled german day care study. Dtsch Arztebl Int. 2017;114(48):815–21. https://doi.org/10.3238/arztebl.2017.0815.CrossRefPubMedPubMedCentral

21.

Graessel E, Stemmer R, Eichenseer B, Pickel S, Donath C, Kornhuber J, et al. Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomised, controlled trial. BMC Med. 2011;9(1):129. https://doi.org/10.1186/1741-7015-9-129.CrossRefPubMedPubMedCentral

22.

Luttenberger K, Hofner B, Graessel E. Are the effects of a non-drug multimodal activation therapy of dementia sustainable? follow-up study 10 months after completion of a randomised controlled trial. BioMed Central Neurol. 2012;12(1):151. https://doi.org/10.1186/1471-2377-12-151.CrossRef

23.

Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586. https://doi.org/10.1136/bmj.e7586.CrossRefPubMedPubMedCentral

24.

O'Caoimh R, Timmons S, Molloy DW. Screening for mild cognitive impairment: comparison of "MCI specific" screening instruments. J Alzheimers Dis. 2016;51(2):619–29. https://doi.org/10.3233/JAD-150881.CrossRefPubMedPubMedCentral

25.

Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922–35. https://doi.org/10.1111/j.1532-5415.1992.tb01992.x.CrossRefPubMed

26.

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.CrossRefPubMed

27.

Freitas S, Simoes MR, Alves L, Santana I. Montreal Cognitive Assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(1):37–43. https://doi.org/10.1097/WAD.0b013e3182420bfe.CrossRefPubMed

28.

Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatr. 2012;24(3):391–6. https://doi.org/10.1017/S1041610211001839.CrossRefPubMed

29.

Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr. 2012;24(11):1749–55. https://doi.org/10.1017/S1041610212001068.CrossRefPubMed

30.

Freitas S, Simoes MR, Maroco J, Alves L, Santana I. Construct validity of the Montreal Cognitive Assessment (MoCA). J Int Neuropsychol Soc. 2012;18(2):242–50. https://doi.org/10.1017/S1355617711001573.CrossRefPubMed

31.

Folstein M, Folstein S. Mc Hugh P: “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. https://doi.org/10.1016/0022-3956(75)90026-6.CrossRefPubMed

32.

Arevalo-Rodriguez I, Smailagic N, Roque IFM, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;3:CD010783. https://doi.org/10.1002/14651858.CD010783.pub2.CrossRef

33.

Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1:CD011145. https://doi.org/10.1002/14651858.CD011145.pub2.CrossRef

34.

Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(9):1450–8. https://doi.org/10.1001/jamainternmed.2015.2152.CrossRefPubMed

35.

Wechsler D. Wechsler adult intelligence scale–fourth edition (WAIS-IV)–Deutsche Version. Frankfurt/Main: Pearson Assessment; 2012.

36.

Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev. 1996;103(3):403–28. https://doi.org/10.1037/0033-295X.103.3.403.CrossRefPubMed

37.

Lehfeld H, Schläfke S, Hoerr R, Stemmler M. SKT Short Cognitive Performance Test and activities of daily living in dementia. GeroPsych. 2014;27(2):75–80. https://doi.org/10.1024/1662-9647/a000104.CrossRef

38.

Henik A, Tzelgov J. Is three greater than five: The relation between physical land semantic size in comparison tasks. Mem Cogn. 1982;10(4):389–95. https://doi.org/10.3758/BF03202431.CrossRef

39.

Kaufmann L, Ischebeck A, Weiss E, Koppelstaetter F, Siedentopf C, Vogel SE, et al. An fMRI study of the numerical Stroop task in individuals with and without minimal cognitive impairment. Cortex. 2008;44(9):1248–55. https://doi.org/10.1016/j.cortex.2007.11.009.CrossRefPubMed

40.

Raven JC, Court JH. Manual for Raven's Progressive matrices and vocabulary scales. London: H.K. Lewis; 1986.

41.

Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

42.

Löwe B, Spitzer RL, Zipfel S, Herzog W. PHQ-D. Gesundheitsfragebogen für Patienten. Manual, 2 edn: Pfizer; 2002.

43.

Kroenke K, Spitzer RL, Williams JBW, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59. https://doi.org/10.1016/j.genhosppsych.2010.03.006.CrossRefPubMed

44.

Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract. 2007;57(541):650–2.PubMedPubMedCentral

45.

Cummings JL. Neuropsychiatrisches Inventar (NPI). In: Neuropsychiatric Inventory. An instrument for assessment of neuropsychiatric symptoms in patients and neurologic disorders. Los Angeles: Edited by UCLA School of Medicine RNRC; 1994.

46.

Laugwitz B, Held T, Schrepp M. Construction and evaluation of a User Experience Questionnaire. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 63–76.

47.

DeYoung N, Shenal BV. The reliability of the Montreal Cognitive Assessment using telehealth in a rural setting with veterans. J Telemed Telecare. 2019;25(4):197–203. https://doi.org/10.1177/1357633X17752030.CrossRefPubMed

48.

Wadsworth HE, Galusha-Glasscock JM, Womack KB, Quiceno M, Weiner MF, Hynan LS, et al. Remote neuropsychological assessment in rural american indians with and without cognitive impairment. Arch Clin Neuropsychol. 2016;31(5):420–55. https://doi.org/10.1093/arclin/acw030.CrossRefPubMedPubMedCentral

49.

Marra DE, Hamlet KM, Bauer RM, Bowers D. Validity of teleneuropsychology for older adults in response to COVID-19: A systematic and critical review. Clin Neuropsychol. 2020;34(7-8):1411–52. https://doi.org/10.1080/13854046.2020.1769192.CrossRefPubMedPubMedCentral

50.

Adams JL, Myers TL, Waddell EM, Spear KL, Schneider RB. Telemedicine: A valuable tool in neurodegenerative diseases. Curr Geriatr Rep. 2020;9(2):72–81. https://doi.org/10.1007/s13670-020-00311-z.CrossRefPubMedPubMedCentral

51.

Costanzo MC, Arcidiacono C, Rodolico A, Panebianco M, Aguglia E, Signorelli MS. Diagnostic and interventional implications of telemedicine in Alzheimer's disease and mild cognitive impairment: A literature review. Int J Geriatr Psychiatry. 2020;35(1):12–28. https://doi.org/10.1002/gps.5219.CrossRefPubMed

Title: Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial
Authors: Stephanie Book
Michael Jank
Anna Pendergrass
Elmar Graessel
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Dementia
Dementia
Mild Neurocognitive Disorder
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06152-9

2024 ASCO Annual Meeting

Springer Medicine

Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial

Abstract

Background

Methods

Discussion

Trial registration

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

Effect of high-flow nasal therapy on patient-centred outcomes in patients at high risk of postoperative pulmonary complications after cardiac surgery: a study protocol for a multicentre adaptive randomised controlled trial

Effect of an artificial intelligence-assisted tool on non-valvular atrial fibrillation anticoagulation management in primary care: protocol for a cluster randomized controlled trial

Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial

Effectiveness of intensive perioperative nutrition therapy among adults undergoing gastrointestinal and oncological surgery in a public hospital: study protocol for a pragmatic randomized control trial

Interpreting a Bayesian phase II futility clinical trial

Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial